Back to FDA Applications sponsored by ALCON

FDA Drug Application 020474 by ALCON

Application Number020474
Application Type New Drug Application
Sponsor ApplicantALCON
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP012/30/1994N       
AP05/10/1995SCE       
AP08/14/1996SLR       
AP03/20/1998SCS       
AP05/1/1998SCM       
AP03/26/1999SCM       
AP011/9/1999SCP       
AP09/11/1998SLR       
AP01/22/1999SCS       
AP03/11/1999SCS       
AP02/5/1999SCM       
AP04/7/1999SCM       
AP08/17/1999SCS       
AP02/18/2000SCM       
AP09/18/2000SCF       
AP03/16/2001SCS       
AP04/17/2003SLR5664016   http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20474slr016_vexol_lbl.pdf 5/29/2003
AP04/17/2003SLR5696016   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20474slr016ltr.pdf 5/29/2003
AP010/18/2007SLR18257019   http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020474s019lbl.pdf 10/22/2007
AP010/18/2007SLR18276019   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020474s019ltr.pdf 10/22/2007
AP02/22/2012SLR31880021   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020474s021lbl.pdf 2/24/2012
AP02/22/2012SLR31904021   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020474s021ltr.pdf 2/27/2012




Back to FDA Applications sponsored by ALCON